Reuters logo
1 年前
BRIEF-Shionogi says NDA submitted in U.S. for Naldemedine accepted for review
2016年6月6日 / 中午12点22分 / 1 年前

BRIEF-Shionogi says NDA submitted in U.S. for Naldemedine accepted for review

June 6 (Reuters) - Shionogi & Co Ltd :

* New Drug Application submitted in U.S. for Naldemedine, a once-daily, oral 0.2 mg tablet, has been accepted for review Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below